Resmed has added a chief investor relations … [Read more...]
Resmed Hires Chief Investor Relations Officer
Resmed Allays Tariff Concerns, Reports Strong Revenue Growth in Q3 Earnings Call
CEO Mick Farrell credited “excellent top line and bottom line results” to the company’s “disciplined execution to capture growing demand for our products.”
Resmed CEO Mick Farrell (NYSE: RMD) reported … [Read more...]
Public Comments on NIPPV National Coverage Determination Due April 10
Patient advocates are concerned by the proposed Medicare requirements for noninvasive positive pressure ventilation.
The public comment period for Medicare’s proposed … [Read more...]
Quipt General Meeting: Provider Emphasizes Multiple Growth Strategies, Strengthening Referral Networks
Quipt Home Medical Corp. also added four members to its board.
Quipt Home Medical Corp. (Nasdaq: QIPT) will be … [Read more...]
CMS Releases National Coverage Analysis for Noninvasive Positive Pressure Ventilation to Treat COPD
Public comments are being accepted until April 10.
The Centers for Medicare & Medicaid Services … [Read more...]
VieMed CEO: ‘Blue Ocean of Opportunity’ to Serve More Patients, Grow Business
In its year-end 2024 earnings call, the HME provider discussed strong ventilator, sleep sales.
VieMed CEO Casey Hoyt has described an enormous … [Read more...]
Fisher & Paykel to Construct Fifth Building in New Zealand
The new facility is expected to open in 2027.
Fisher & Paykel Healthcare Corp. (NZX: FPH) is … [Read more...]
CAIRE Adds Accurate Biomed Services to Authorized Service Network
Accurate Biomed is one of the nation’s largest independent service providers for respiratory and biomedical equipment.
Respiratory patients needing service for their … [Read more...]
Patient-Direct Segment Takes Center Stage as Owens & Minor Considers Divesting Enterprise-Focused Business Line
The company is considering a sale of its products and health-care services segment, which mainly serves institutional providers.
Owens & Minor (NYSE: OMI) is putting all its … [Read more...]
AdaptHealth Posts $3.26B in 2024 Revenue; CEO Highlights AI, Diabetes Turnaround, Capitated Contracts
Growth in respiratory, sleep segments offset declines in diabetes health, the company reported.
AdaptHealth (Nasdaq: AHCO) closed out 2024 on a … [Read more...]